Publications by authors named "F Peter Treasure"

Claim this Profile
R
Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome.
Eamonn M M Quigley, Louise Markinson, Alex Stevenson, F Peter Treasure, Brian E Lacy

Aliment Pharmacol Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia.
Deborah P Merke, Ashwini Mallappa, Wiebke Arlt, Aude Brac de la Perriere, Angelica Lindén Hirschberg, F Peter Treasure

J Clin Endocrinol Metab· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Stephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, Neal D Shore, Leonard G Gomella, F Peter Treasure

Lancet Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
Neal D Shore, Stephen A Boorjian, Daniel J Canter, Kenneth Ogan, Lawrence I Karsh, F Peter Treasure

J Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential surrogate endpoints in cancer research--some considerations and examples.
S W Duffy, F P Treasure

Pharm Stat· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis